ARTICLE | Company News
Aspen, GlaxoSmithKline deal
December 7, 2009 8:00 AM UTC
GlaxoSmithKline completed the transfer of worldwide rights to eight off-patent products to Aspen in exchange for 68.5 million shares of the generics company, bringing the pharma's holdings to 81.7 mil...